Skip to content
DraconiticResearch
Search Sources API
186,541 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY-NC-NDGeriatrics & gerontology international

Comparison of Metabolic Dysfunction‐Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin‐Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices

  • Makoto Miyabayashi1
  • Masaya Koshizaka1
  • Mayumi Shoji1
  • Hiyori Kaneko1
  • Kazuto Aono1
  • Hisaya Kato1
  • Tetta Sato1
  • Takuro Horikoshi1
  • Mai Ishikawa2
  • Akiko Sekiguchi2
  • Sei‐Ichiro Motegi2
  • Shinji Tsukamoto3
20 more authors
  • Akira Taniguchi4
  • Yukiko Shoda5
  • Toru Yoshimura6
  • Junji Kawashima7
  • Kayo Yoshinaga7
  • Hironori Nakagami8
  • Yoichi Takami8
  • Ken Sugimoto9
  • Kunihiko Hashimoto10
  • Naoki Okubo11
  • Masato Ohara11
  • Takashi Yoshida11
  • Asako Kogure12
  • Daisuke Suzuki12
  • Masafumi Kuzuya13
  • Kazuhisa Watanabe14
  • Minoru Takemoto15
  • Junko Oshima16
  • Yoshiro Maezawa1
  • Koutaro Yokote17
17 affiliations
  1. 1Chiba University Graduate School of Medicine
  2. 2Gunma University Graduate School of Medicine
  3. 3Nara Medical University
  4. 4Higashiosaka City Medical Center
  5. 5Sumitomo Hospital
  6. 6Saga‐Ken Medical Centre Koseikan
  7. 7Kumamoto University
  8. 8Osaka University Graduate School of Medicine
  9. 9Kawasaki Medical School
  10. 10Nippon Life Hospital
  11. 11Kyoto Prefectural University of Medicine
  12. 12Showa General Hospital
  13. 13Meitetsu Hospital
  14. 14Nagoya University Graduate School of Medicine
  15. 15International University of Health and Welfare
  16. 16University of Washington
  17. 17Chiba University
Read full textPDFCite

Related

  1. Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
    Mohammed Alfawaz, Dareen Bajamaan, Lama Alghamdi +7
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis
    Zhenghong Xie, Tianxing Chen
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Tirzepatide use in adolescents with metabolic dysfunction‐associated steatotic liver disease (MASLD): A case series
    Brandon J. Perumpail, Andrea Tou, Jennifer Panganiban
    JPGN reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Functional and Metabolic Correlates of Age- and Sex-Normalized Handgrip Strength in Children with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Mohit Kehar, Carolina Jimenez-Rivera, Leah Feret +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)
    Xinyue Pang, Nan Geng, Chenqi Lu +5
    Hepatology communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{miyabayashi2026comparison,
  title = {{Comparison of Metabolic Dysfunction‐Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin‐Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices}},
  author = {Makoto Miyabayashi and Masaya Koshizaka and Mayumi Shoji and Hiyori Kaneko and Kazuto Aono and Hisaya Kato and Tetta Sato and Takuro Horikoshi and Mai Ishikawa and Akiko Sekiguchi and Sei‐Ichiro Motegi and Shinji Tsukamoto and Akira Taniguchi and Yukiko Shoda and Toru Yoshimura and Junji Kawashima and Kayo Yoshinaga and Hironori Nakagami and Yoichi Takami and Ken Sugimoto and Kunihiko Hashimoto and Naoki Okubo and Masato Ohara and Takashi Yoshida and Asako Kogure and Daisuke Suzuki and Masafumi Kuzuya and Kazuhisa Watanabe and Minoru Takemoto and Junko Oshima and Yoshiro Maezawa and Koutaro Yokote},
  journal = {Geriatrics \& gerontology international},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13662814},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Comparison of Metabolic Dysfunction‐Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin‐Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices
AU  - Makoto Miyabayashi
AU  - Masaya Koshizaka
AU  - Mayumi Shoji
AU  - Hiyori Kaneko
AU  - Kazuto Aono
AU  - Hisaya Kato
AU  - Tetta Sato
AU  - Takuro Horikoshi
AU  - Mai Ishikawa
AU  - Akiko Sekiguchi
AU  - Sei‐Ichiro Motegi
AU  - Shinji Tsukamoto
AU  - Akira Taniguchi
AU  - Yukiko Shoda
AU  - Toru Yoshimura
AU  - Junji Kawashima
AU  - Kayo Yoshinaga
AU  - Hironori Nakagami
AU  - Yoichi Takami
AU  - Ken Sugimoto
AU  - Kunihiko Hashimoto
AU  - Naoki Okubo
AU  - Masato Ohara
AU  - Takashi Yoshida
AU  - Asako Kogure
AU  - Daisuke Suzuki
AU  - Masafumi Kuzuya
AU  - Kazuhisa Watanabe
AU  - Minoru Takemoto
AU  - Junko Oshima
AU  - Yoshiro Maezawa
AU  - Koutaro Yokote
PY  - 2026
DA  - 2026/10/01
JO  - Geriatrics & gerontology international
UR  - https://europepmc.org/article/PMC/PMC13662814
SN  - 1444-1586
SN  - 1447-0594
ER  -